Increase/Decrease in Cash: The total change in cash for the company over the given period.
Mainz Biomed NV (MYNZ) had Increase/Decrease in Cash of $-6.09M for the most recently reported fiscal quarter, ending 2024-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$2.39M |
|
$1.63M |
|
$6.06M |
|
$8.45M |
|
$10.01M |
|
$1.05M |
|
$2.58M |
|
$12.59M |
|
$-4.14M |
|
$-7.34M |
|
$-4.14M |
|
0.64M |
|
| Cash Flow Statement Financials | |
$-8.14M |
|
$-0.42M |
|
$2.55M |
|
$7.07M |
|
$0.98M |
|
|
Increase/Decrease in Cash |
$-6.09M |
$1.03M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|